Found: 68
Select item for more details and to access through your institution.
Phase I study of S-1 plus paclitaxel combination therapy as a first-line treatment in elderly patients with advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 291, doi. 10.1007/s10637-018-0656-z
- By:
- Publication type:
- Article
Nab-paclitaxel maintenance therapy following carboplatin + nab-paclitaxel combination therapy in chemotherapy naïve patients with advanced non-small cell lung cancer: multicenter, open-label, single-arm phase II trial.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 5, p. 903, doi. 10.1007/s10637-018-0617-6
- By:
- Publication type:
- Article
Elevation of serum C-reactive protein predicts failure of the initial antimicrobial treatment for febrile neutropenia with lung cancer.
- Published in:
- Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2013, v. 19, n. 2, p. 202, doi. 10.1007/s10156-012-0474-8
- By:
- Publication type:
- Article
The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma.
- Published in:
- Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2012, v. 18, n. 5, p. 668, doi. 10.1007/s10156-012-0391-x
- By:
- Publication type:
- Article
The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease.
- Published in:
- Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2012, v. 18, n. 2, p. 146, doi. 10.1007/s10156-011-0303-5
- By:
- Publication type:
- Article
Identifying risk factors for refractory febrile neutropenia in patients with lung cancer.
- Published in:
- Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2012, v. 18, n. 1, p. 53, doi. 10.1007/s10156-011-0283-5
- By:
- Publication type:
- Article
The Impact of VEGF Inhibition on Clinical Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy: A Retrospective Cohort Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.663612
- By:
- Publication type:
- Article
Immune-Related Adverse Events Are Associated With Clinical Benefit in Patients With Non-Small-Cell Lung Cancer Treated With Immunotherapy Plus Chemotherapy: A Retrospective Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.630136
- By:
- Publication type:
- Article
Late-onset Pleural and Pericardial Effusion as Immune-related Adverse Events after 94 Cycles of Nivolumab.
- Published in:
- Internal Medicine, 2021, v. 60, n. 22, p. 3585, doi. 10.2169/internalmedicine.7219-21
- By:
- Publication type:
- Article
Shared decision making for the initiation and continuation of dialysis: a proposal from the Japanese Society for Dialysis Therapy.
- Published in:
- Renal Replacement Therapy, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s41100-021-00365-5
- By:
- Publication type:
- Article
The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations.
- Published in:
- 2018
- By:
- Publication type:
- journal article
HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00250-8
- By:
- Publication type:
- Article
HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00250-8
- By:
- Publication type:
- Article
364. Prevention of Radiation Pneumonitis by Recombinant Adenovirus-Mediated Transfer of Soluble TGF-βtype II Receptor Gene
- Published in:
- 2005
- By:
- Publication type:
- Abstract
322. Tumor Specific Activation of Irinotecan by a Carboxylesterase Fused with Anti CEA scFv
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer.
- Published in:
- Advanced Science, 2021, v. 8, n. 4, p. 1, doi. 10.1002/advs.202003263
- By:
- Publication type:
- Article
Safety and tolerability of PD-1/PD-L1 inhibitors in elderly and frail patients with advanced malignancies.
- Published in:
- Oncology Letters, 2020, v. 20, n. 4, p. N.PAG
- By:
- Publication type:
- Article
Clinical features of immune-related thyroid dysfunction and its association with outcomes in patients with advanced malignancies treated by PD-1 blockade.
- Published in:
- Oncology Letters, 2019, v. 18, n. 2, p. 2140, doi. 10.3892/ol.2019.10466
- By:
- Publication type:
- Article
Chronic Pseudomonas aeruginosa infection-induced chronic bronchitis and emphysematous changes in CCSP-deficient mice.
- Published in:
- International Journal of COPD, 2016, v. 11, p. 2321, doi. 10.2147/COPD.S113707
- By:
- Publication type:
- Article
Critical role of tumor necrosis factor receptor 1 in the pathogenesis of pulmonary emphysema in mice.
- Published in:
- International Journal of COPD, 2016, v. 11, p. 1705, doi. 10.2147/COPD.S108919
- By:
- Publication type:
- Article
Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatment.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 9, p. 737, doi. 10.1038/sj.cgt.7700838
- By:
- Publication type:
- Article
Impact of maintenance therapy following induction immunochemotherapy for untreated advanced non-small cell lung cancer patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 11, p. 2985, doi. 10.1007/s00432-021-03866-2
- By:
- Publication type:
- Article
Early discontinuation of induction therapy in chemoimmunotherapy as an effective alternative to the standard regimen in patients with non-small cell lung cancer: a retrospective study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 9, p. 2437, doi. 10.1007/s00432-021-03782-5
- By:
- Publication type:
- Article
Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 2, p. 457, doi. 10.1007/s00432-019-03072-1
- By:
- Publication type:
- Article
Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases: A Multicenter, Open-Label Single-Arm Phase II Trial.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 551, doi. 10.1093/oncolo/oyad013
- By:
- Publication type:
- Article
Randomized Phase II Study of First‐Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non‐Small Cell Lung Cancer: LOGIK0801.
- Published in:
- Oncologist, 2020, v. 25, n. 8, p. e1146, doi. 10.1634/theoncologist.2020-0322
- By:
- Publication type:
- Article
Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. 208, doi. 10.1634/theoncologist.2019-0717
- By:
- Publication type:
- Article
Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1420, doi. 10.1634/theoncologist.2019-0513
- By:
- Publication type:
- Article
Phase II Study of S‐1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. 1033, doi. 10.1634/theoncologist.2019-0290
- By:
- Publication type:
- Article
Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M‐Positive Non‐Small‐Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial.
- Published in:
- Oncologist, 2019, v. 24, n. 5, p. 593, doi. 10.1634/theoncologist.2019-0003
- By:
- Publication type:
- Article
A Phase II Study of S‐1 and Paclitaxel Combination Therapy as a First‐Line Treatment in Elderly Patients with Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 459, doi. 10.1634/theoncologist.2018-0858
- By:
- Publication type:
- Article
Rationale and Design of a Phase II Trial of Osimertinib Combined With Bevacizumab in Patients With Untreated Epidermal Growth Factor Receptor-mutated Non-small-cell Lung Cancer and Malignant Pleural and/or Pericardial Effusion (SPIRAL II Study).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Retrospective efficacy analysis of immune checkpoint inhibitors in patients with EGFR‐mutated non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 4, p. 1521, doi. 10.1002/cam4.2037
- By:
- Publication type:
- Article
Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 2, p. 423, doi. 10.3390/diagnostics12020423
- By:
- Publication type:
- Article
Species D Human Adenovirus Type 9 Exhibits Better Virus-Spread Ability for Antitumor Efficacy among Alternative Serotypes.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0087342
- By:
- Publication type:
- Article
A multicenter, open‐label, single‐arm study of anamorelin (ONO‐7643) in patients with cancer cachexia and low body mass index.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 10, p. 2025, doi. 10.1002/cncr.34154
- By:
- Publication type:
- Article
Comparison of Body Fluid Volumes Determined by Kinetic Modeling and by Bioimpedance Spectroscopy.
- Published in:
- Blood Purification, 2022, v. 51, n. 10, p. 866, doi. 10.1159/000521563
- By:
- Publication type:
- Article
Purification of Dialysis Water in the Central Dialysis Fluid Delivery System in Japan: A Prospective Observation Study.
- Published in:
- Blood Purification, 2009, v. 27, p. 64, doi. 10.1159/000213500
- By:
- Publication type:
- Article
Guidance of Technical Management of Dialysis Water and Dialysis Fluid for the Japan Association for Clinical Engineering Technologists.
- Published in:
- Blood Purification, 2009, v. 27, p. 41, doi. 10.1159/000213497
- By:
- Publication type:
- Article
Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations.
- Published in:
- Proteomes, 2023, v. 11, n. 1, p. 6, doi. 10.3390/proteomes11010006
- By:
- Publication type:
- Article
Rationale and design of a phase II trial of durvalumab treatment in patients with NSCLC ineligible for stage III chemoradiotherapy following radiation monotherapy (SPIRAL-RT study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920927841
- By:
- Publication type:
- Article
Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
- Published in:
- 2018
- By:
- Publication type:
- journal article
2011 JSDT Standard on the Management of Endotoxin Retentive Filter for Dialysis and Related Therapies.
- Published in:
- Therapeutic Apheresis & Dialysis, 2013, v. 17, n. 2, p. 229, doi. 10.1111/1744-9987.12031
- By:
- Publication type:
- Article
Comparison of Sevelamer Hydrochloride With Colestimide, Administered Alone or in Combination With Calcium Carbonate, in Patients on Hemodialysis.
- Published in:
- Therapeutic Apheresis & Dialysis, 2008, v. 12, n. 2, p. 126, doi. 10.1111/j.1744-9987.2008.00557.x
- By:
- Publication type:
- Article
Prophylactic treatment of dacomitinib‐induced skin toxicities in epidermal growth factor receptor‐mutated non–small‐cell lung cancer: A multicenter, Phase II trial.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 14, p. 15117, doi. 10.1002/cam4.6184
- By:
- Publication type:
- Article
Advanced Non-Small-Cell Lung Cancer in Elderly Patients: Patient Features and Therapeutic Management.
- Published in:
- BioMed Research International, 2018, v. 2018, p. 1, doi. 10.1155/2018/8202971
- By:
- Publication type:
- Article
Significance of inflammatory indexes in atezolizumab monotherapy outcomes in previously treated non-small-cell lung cancer patients.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-74573-0
- By:
- Publication type:
- Article
Impact of preexisting antinuclear antibodies on combined immunotherapy and chemotherapy in advanced non-small cell lung cancer patients.
- Published in:
- Medical Oncology, 2020, v. 37, n. 12, p. 1, doi. 10.1007/s12032-020-01440-3
- By:
- Publication type:
- Article
Serum immune modulators during the first cycle of anti‐PD‐1 antibody therapy in non‐small cell lung cancer: Perforin as a biomarker.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 11, p. 3223, doi. 10.1111/1759-7714.13650
- By:
- Publication type:
- Article
Efficacy and safety of S‐1 monotherapy in previously treated elderly patients (aged ≥75 years) with non‐small cell lung cancer: A retrospective analysis.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 10, p. 2867, doi. 10.1111/1759-7714.13622
- By:
- Publication type:
- Article